CDC25C and neoplasm: According to the analyses between phospho-CDC25C (Ser 216) and clinical parameters, high expression of phospho-CDC25C (Ser 216) in cytoplasm/nucleus was significantly correlated with advanced FIGO stage, large tumor diameter and deep invasion as well as poor disease-specific survival.